Wall Street brokerages expect Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) to post $0.11 earnings per share (EPS) for the current quarter, Zacks reports. Ten analysts have issued estimates for Allscripts Healthcare Solutions’ earnings, with the lowest EPS estimate coming in at $0.10 and the highest estimate coming in at $0.13. Allscripts Healthcare Solutions posted earnings per share of $0.10 in the same quarter last year, which would indicate a positive year over year growth rate of 10%. The business is expected to issue its next earnings results after the market closes on Thursday, August 3rd.

According to Zacks, analysts expect that Allscripts Healthcare Solutions will report full year earnings of $0.49 per share for the current fiscal year, with EPS estimates ranging from $0.47 to $0.51. For the next financial year, analysts forecast that the business will report earnings of $0.54 per share, with EPS estimates ranging from $0.52 to $0.57. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that cover Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Thursday, May 4th. The software maker reported $0.10 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.09 by $0.01. Allscripts Healthcare Solutions had a positive return on equity of 5.75% and a negative net margin of 2.93%. The business had revenue of $415 million for the quarter, compared to analyst estimates of $415.20 million. During the same quarter in the previous year, the company earned $0.13 EPS. The company’s quarterly revenue was up 20.1% on a year-over-year basis.

MDRX has been the topic of several recent research reports. Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, April 19th. Leerink Swann downgraded shares of Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and dropped their price target for the stock from $15.00 to $13.00 in a research note on Monday, June 19th. Cantor Fitzgerald reissued a “neutral” rating and set a $13.00 price target on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. Maxim Group reissued a “buy” rating and set a $16.00 price target on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. Finally, BidaskClub raised shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, June 24th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $14.74.

Allscripts Healthcare Solutions (MDRX) opened at 12.51 on Thursday. The firm has a 50-day moving average price of $12.43 and a 200 day moving average price of $12.09. Allscripts Healthcare Solutions has a one year low of $9.80 and a one year high of $15.17. The firm’s market capitalization is $2.27 billion.

ILLEGAL ACTIVITY WARNING: “Allscripts Healthcare Solutions, Inc. (MDRX) Expected to Post Earnings of $0.11 Per Share” was first posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/07/27/allscripts-healthcare-solutions-inc-mdrx-expected-to-post-earnings-of-0-11-per-share.html.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 25,000 shares of Allscripts Healthcare Solutions stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $12.06, for a total transaction of $301,500.00. Following the transaction, the president now directly owns 412,488 shares of the company’s stock, valued at approximately $4,974,605.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.75% of the company’s stock.

Several institutional investors have recently modified their holdings of MDRX. Norges Bank purchased a new stake in shares of Allscripts Healthcare Solutions during the fourth quarter worth about $28,999,000. First Trust Advisors LP boosted its stake in shares of Allscripts Healthcare Solutions by 48.0% in the first quarter. First Trust Advisors LP now owns 5,855,944 shares of the software maker’s stock worth $74,253,000 after buying an additional 1,898,007 shares in the last quarter. Fiduciary Management Inc. WI boosted its stake in shares of Allscripts Healthcare Solutions by 28.5% in the first quarter. Fiduciary Management Inc. WI now owns 6,045,110 shares of the software maker’s stock worth $76,652,000 after buying an additional 1,341,870 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Allscripts Healthcare Solutions by 9.4% in the first quarter. Dimensional Fund Advisors LP now owns 7,227,789 shares of the software maker’s stock worth $91,648,000 after buying an additional 621,620 shares in the last quarter. Finally, Blue Jay Capital Management LLC purchased a new stake in shares of Allscripts Healthcare Solutions during the first quarter worth about $7,481,000.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.